Copyright © DrugPatentWatch. Originally published at New patent for Coeptis drug CONSENSI
Annual Drug Patent Expirations for CONSENSI
Consensi is a drug marketed by Coeptis and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has nine patent family members in seven countries.
The generic ingredient in CONSENSI is amlodipine besylate; celecoxib. One supplier is listed for this compound. Additional details are available on the amlodipine besylate; celecoxib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
Copyright © DrugPatentWatch. Originally published at New patent for Coeptis drug CONSENSI
Related
Source: https://www.drugpatentwatch.com/blog/new-patent-for-coeptis-drug-consensi/
